Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
8.76
+0.35 (4.16%)
At close: Jan 6, 2026, 4:00 PM EST
8.66
-0.10 (-1.14%)
After-hours: Jan 6, 2026, 6:42 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Novel Therapeutics
3.95M
Log In
Log In
Log In
Novel Therapeutics Growth
-74.60%
Log In
Log In
Log In